BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wallace PM, Suzuki R. Regional, racial, and gender differences in colorectal cancer screening in middle-aged African-Americans and Whites. J Cancer Educ. 2012;27:703-708. [PMID: 22791544 DOI: 10.1007/s13187-012-0396-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Johnson MR, Grubber J, Grambow SC, Maciejewski ML, Dunn-Thomas T, Provenzale D, Fisher DA. Physician Non-adherence to Colonoscopy Interval Guidelines in the Veterans Affairs Healthcare System. Gastroenterology 2015;149:938-51. [PMID: 26122143 DOI: 10.1053/j.gastro.2015.06.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
2 Martinez KA, Pollack CE, Phelan DF, Markakis D, Bone L, Shapiro G, Wenzel J, Howerton M, Johnson L, Garza MA, Ford JG. Gender differences in correlates of colorectal cancer screening among Black Medicare beneficiaries in Baltimore. Cancer Epidemiol Biomarkers Prev 2013;22:1037-42. [PMID: 23629519 DOI: 10.1158/1055-9965.EPI-12-1215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rogers CR, Okuyemi K, Paskett ED, Thorpe RJ Jr, Rogers TN, Hung M, Zickmund S, Riley C, Fetters MD. Study protocol for developing #CuttingCRC: a barbershop-based trial on masculinity barriers to care and colorectal cancer screening uptake among African-American men using an exploratory sequential mixed-methods design. BMJ Open 2019;9:e030000. [PMID: 31345981 DOI: 10.1136/bmjopen-2019-030000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Han PK, Duarte CW, Daggett S, Siewers A, Killam B, Smith KA, Freedman AN. Effects of personalized colorectal cancer risk information on laypersons' interest in colorectal cancer screening: The importance of individual differences. Patient Educ Couns 2015;98:1280-6. [PMID: 26227576 DOI: 10.1016/j.pec.2015.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dorsey K, Zhou Z, Masaoud R, Nimeiri HS. Health Care Disparities in the Treatment of Colorectal Cancer. Curr Treat Options in Oncol 2013;14:405-14. [DOI: 10.1007/s11864-013-0241-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Xiao W, Zhao H, Dong W, Li Q, Zhu J, Li G, Zhang S, Ye M. Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer. Oncol Lett 2015;9:1383-7. [PMID: 25663916 DOI: 10.3892/ol.2014.2815] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
7 Thirumurthi S, Raju GS, Pande M, Ruiz J, Carlson R, Hagan KB, Lee JH, Ross WA. Does deep sedation with propofol affect adenoma detection rates in average risk screening colonoscopy exams? World J Gastrointest Endosc 2017; 9(4): 177-182 [PMID: 28465784 DOI: 10.4253/wjge.v9.i4.177] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
8 McKinney SY, Palmer RC. The influence of gender on colorectal cancer knowledge, screening intention, perceived risk and worry among African Americans in South Florida. J Community Health 2014;39:230-8. [PMID: 24375289 DOI: 10.1007/s10900-013-9812-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sullivan DA, Rocha EM, Aragona P, Clayton JA, Ding J, Golebiowski B, Hampel U, McDermott AM, Schaumberg DA, Srinivasan S, Versura P, Willcox MDP. TFOS DEWS II Sex, Gender, and Hormones Report. Ocul Surf 2017;15:284-333. [PMID: 28736336 DOI: 10.1016/j.jtos.2017.04.001] [Cited by in Crossref: 128] [Cited by in F6Publishing: 109] [Article Influence: 25.6] [Reference Citation Analysis]
10 Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical Mistrust and Colorectal Cancer Screening Among African Americans. J Community Health 2017;42:1044-61. [PMID: 28439739 DOI: 10.1007/s10900-017-0339-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
11 Rust G, Zhang S, Yu Z, Caplan L, Jain S, Ayer T, McRoy L, Levine RS. Counties eliminating racial disparities in colorectal cancer mortality. Cancer 2016;122:1735-48. [PMID: 26969874 DOI: 10.1002/cncr.29958] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
12 Kumar A, Peixoto RD, Kennecke HF, Renouf DJ, Lim HJ, Gill S, Speers CH, Cheung WY. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer. Clin Colorectal Cancer 2015;14:262-8.e1. [PMID: 26123496 DOI: 10.1016/j.clcc.2015.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
13 Horner-Johnson W, Dobbertin K, Lee JC, Andresen EM. Rural disparities in receipt of colorectal cancer screening among adults ages 50-64 with disabilities. Disabil Health J 2014;7:394-401. [PMID: 25065974 DOI: 10.1016/j.dhjo.2014.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
14 Lee J, Carvallo M. Socioecological perspectives on cervical cancer and cervical cancer screening among Asian American women. J Community Health 2014;39:863-71. [PMID: 24863746 DOI: 10.1007/s10900-014-9887-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
15 May FP, Whitman CB, Varlyguina K, Bromley EG, Spiegel BM. Addressing Low Colorectal Cancer Screening in African Americans: Using Focus Groups to Inform the Development of Effective Interventions. J Cancer Educ 2016;31:567-74. [PMID: 25963898 DOI: 10.1007/s13187-015-0842-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]